Circassia Pharmaceuticals (LON:CIR)

Circassia Pharmaceuticals (LON:CIR)

Share Price
20.40 p
1.75 (9.38 %)
Market Cap
£76.53 m
Proactive Investors - Run By Investors For Investors

Circassia Pharmaceuticals

Circassia is a specialty pharmaceutical company focused on respiratory disease. Our growing commercial organization promotes our innovative asthma management products directly to specialist physicians in a number of key markets, and we market the chronic obstructive pulmonary disease (COPD) product Tudorza® in the United States. We are expanding our commercial platform in China, and are...

Market: LSE:CIR
52-week High/Low: 82.70p / 13.25p
Sector: Pharma & Biotech
Market Cap: £76.53 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Circassia Pharmaceuticals

Circassia Pharmaceuticals Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use